Executing Effective Commercialisation Strategies: E.U. Vs U.S. | Chief Commercialisation Officer Series | The Venari Podcast

With over 30 years’ experience in launching and leading multi-billion-dollar blockbuster drug launches, Kirsten Detrick is more than qualified to discuss what is needed for successful commercial strategies in biopharma. She was most recently CCO at Endpoint Health, and remains sought-after by biotechs preparing for commercialisation.

Kirsten spoke to our Life Sciences Commercial Consultant, Joe Knight, for the Venari Podcast Chief Commercial Officer series. Listen to their conversation which touched on Kirsten’s journey towards becoming a CCO, commercialisation and talent strategies!